Companion Fund

Companion Fund is a specialized venture capital fund operating under the umbrella of Digitalis Ventures, a New York-based firm focused on health and wellness. Established to exclusively target the rapidly evolving pet care industry, Companion Fund invests in innovative companies that are shaping the future of animal health and well-being. Its investment thesis spans a broad spectrum of the pet care ecosystem, including advanced diagnostics, therapeutics, nutrition, pet technology platforms, and consumer services.

The fund's strategic approach leverages Digitalis Ventures' extensive network and deep expertise in the broader life sciences and health technology sectors. This allows Companion Fund to identify and support disruptive businesses with strong scientific foundations and scalable business models. They typically engage with companies across various stages, from early-stage seed rounds to more mature Series A and B opportunities, providing not just capital but also strategic guidance and operational support to their portfolio companies.

Companion Fund is particularly interested in solutions that address unmet needs in pet health, enhance pet ownership experiences, or introduce novel technologies to the market. The U.S. pet industry alone reached an estimated $136.8 billion in sales in 2022, highlighting the significant market opportunity and the fund's strategic positioning within this growth sector. This focus allows them to contribute to and capitalize on the increasing humanization of pets and the growing demand for high-quality pet products and services.

While specific check sizes for Companion Fund are not always publicly delineated, its parent firm, Digitalis Ventures, closed its third fund (Fund III) at $300 million in 2021. This substantial capital base enables Companion Fund to make meaningful initial investments. Typically, Digitalis Ventures, and by extension Companion Fund, writes initial checks ranging from $500,000 for early-stage opportunities to $5,000,000 for more developed Series A rounds, reflecting their capacity to support significant growth and innovation in the pet care space.